Technical Analysis for RCE - Recce Ltd  

Grade Last Price % Change Price Change
grade C 0.275 3.77% 0.010
RCE closed unchanged on Thursday, December 12, 2019, on 14 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Flat Up
See historical RCE trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 3.77%
Narrow Range Bar Range Contraction 3.77%
Narrow Range Bar Range Contraction 3.77%
NR7 Range Contraction 3.77%
20 DMA Support Bullish 3.77%
20 DMA Support Bullish 1.85%
50 DMA Resistance Bearish 3.77%
Bearish Engulfing Bearish 3.77%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 3.77%
Crossed Above 20 DMA Bullish 0.00%
Older signals for RCE ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Interactive chart

Profile

Recce Limited is an Australia-based research-based pharmaceutical company. The Company is principally engaged in research and development of antibiotic drugs and anticancer drugs. The Company's antibiotics kill both susceptible bacteria and drug resistant super bugs throughout the world health danger arising from resistance to present-day antibiotics. The Company offers antibiotic drugs to treat the diseases caused by Sepsis, Helicobacter Pylori (H.Pylori), Escherichia coli (E.coli), Gonorrhea and Tuberculosis (TB). The Company offers anticancer drugs to treat various cancers, such as leukemia, prostate, lung, stomach, intestine, kidney and melanoma. The Company also offers polymer-antibiotics targeted for human use. The Company's Recce antibiotic kills all types of bacteria, including superbugs. Its subsidiaries include Recce (USA) LLP and Recce (UK) Limited.
Medicine Health Cancer Chemotherapy Diseases Pharmaceuticals Policy Cancers Bacteriology Antibiotics Bacteria Leukemia Melanoma Veterinary Medicine Antibiotic

Is RCE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 0.435
52 Week Low 0.13
Average Volume 428,915
200-Day Moving Average 0.229
50-Day Moving Average 0.274
20-Day Moving Average 0.262
10-Day Moving Average 0.266
Average True Range 0.016
ADX 16.05
+DI 24.465
-DI 19.395
Chandelier Exit (Long, 3 ATRs ) 0.249
Chandelier Exit (Short, 3 ATRs ) 0.287
Upper Bollinger Band 0.279
Lower Bollinger Band 0.245
Percent B (%b) 0.59
BandWidth 12.901
MACD Line -0.001
MACD Signal Line -0.002
MACD Histogram 0.0009
Fundamentals Value
Market Cap 20.22 Million
Num Shares 76.3 Million
EPS -0.04
Price-to-Earnings (P/E) Ratio -6.79
Price-to-Sales 177.95
Price-to-Book 6.21
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.273
Resistance 3 (R3) 0.272 0.268 0.271
Resistance 2 (R2) 0.268 0.266 0.269 0.271
Resistance 1 (R1) 0.267 0.265 0.268 0.268 0.270
Pivot Point 0.263 0.263 0.264 0.264 0.263
Support 1 (S1) 0.262 0.261 0.263 0.263 0.260
Support 2 (S2) 0.258 0.260 0.259 0.259
Support 3 (S3) 0.257 0.258 0.259
Support 4 (S4) 0.258